Short pages

Jump to navigation Jump to search

Showing below up to 50 results in range #87,641 to #87,690.

View ( | ) (20 | 50 | 100 | 250 | 500)

  1. (hist) Sodium hexametaphosphate [3,562 bytes]
  2. (hist) Scoulerine [3,562 bytes]
  3. (hist) Q-Q plot [3,562 bytes]
  4. (hist) Axis (anatomy) [3,562 bytes]
  5. (hist) Diffraction limited [3,562 bytes]
  6. (hist) Billinge Hospital [3,562 bytes]
  7. (hist) Disinhibition [3,562 bytes]
  8. (hist) UDP-N-acetylglucosamine-lysosomal-enzyme N-acetylglucosaminephosphotransferase [3,562 bytes]
  9. (hist) Wiedemann–Rautenstrauch syndrome [3,562 bytes]
  10. (hist) Dopamine reuptake inhibitor [3,563 bytes]
  11. (hist) Gallium(III) phosphide [3,563 bytes]
  12. (hist) Capsicum annuum [3,563 bytes]
  13. (hist) Irish Blood Transfusion Service [3,563 bytes]
  14. (hist) Signal processing [3,563 bytes]
  15. (hist) Biennial plant [3,563 bytes]
  16. (hist) Quinidine side effects [3,563 bytes]
  17. (hist) N-Acetylaspartic acid [3,563 bytes]
  18. (hist) Q fever historical perspective [3,563 bytes]
  19. (hist) WBR0653 [3,563 bytes]
  20. (hist) Chronic hypertension medical therapy blood pressure goals of treatment [3,563 bytes]
  21. (hist) Endrin [3,564 bytes]
  22. (hist) Ferroplasma [3,564 bytes]
  23. (hist) TRNA cytidylyltransferase [3,564 bytes]
  24. (hist) Proglumide [3,564 bytes]
  25. (hist) Potassium sulfide [3,564 bytes]
  26. (hist) HDGFRP3 [3,564 bytes]
  27. (hist) Chronic pancreatitis diagnostic criteria [3,564 bytes]
  28. (hist) Sox2 [3,565 bytes]
  29. (hist) Ethocybin [3,565 bytes]
  30. (hist) Nicosan [3,565 bytes]
  31. (hist) Fucus serratus [3,565 bytes]
  32. (hist) The Living Guidelines: Recommendations for Monitoring of symptoms and anti anginal therapy during follow up Polling Results for CLASS IIb Guidelines [3,565 bytes]
  33. (hist) TRNA (uracil-5-)-methyltransferase [3,565 bytes]
  34. (hist) Clark Leonard Hull [3,565 bytes]
  35. (hist) Indium(III) chloride [3,565 bytes]
  36. (hist) Lansoprazole drug interactions [3,565 bytes]
  37. (hist) TRANSCEND Study suggests that telmisartan reduces cardiovascular events [3,565 bytes]
  38. (hist) Shock laboratory findings [3,565 bytes]
  39. (hist) Nitazoxanide adverse reactions [3,565 bytes]
  40. (hist) C4 glomerulopathy other diagnostic studies [3,565 bytes]
  41. (hist) Complement membrane attack complex [3,566 bytes]
  42. (hist) Chromate [3,566 bytes]
  43. (hist) Benzoylecgonine [3,566 bytes]
  44. (hist) Khyber Medical College [3,566 bytes]
  45. (hist) Depressive realism [3,566 bytes]
  46. (hist) Audism [3,566 bytes]
  47. (hist) African trypanosomiasis epidemiology and demographics [3,566 bytes]
  48. (hist) Aclarubicin [3,566 bytes]
  49. (hist) Non small cell lung cancer [3,566 bytes]
  50. (hist) Granulomatosis with polyangiitis diagnostic study of choice [3,566 bytes]

View ( | ) (20 | 50 | 100 | 250 | 500)